This photograph taken on March 5, 2021 shows the flag of the World Health Organization (WHO) at their headquarters in Geneva amid the Covid-19 coronavirus outbreak. (Photo by Fabrice COFFRINI / AFP) (Photo by FABRICE COFFRINI/AFP via Getty Images)
The coronavirus remains a global health emergency, the World Health Organization chief said Monday, after a key advisory panel found the pandemic may be nearing an “inflexion point” where higher levels of immunity can lower virus-related deaths.
Speaking at the opening of WHO’s annual executive board meeting, WHO Director-General Tedros Adhanom Ghebreyesus said “there is no doubt that we're in a far better situation now” than a year ago — when the highly transmissible Omicron variant was at its peak.
But Tedros warned that in the last eight weeks, at least 170,000 people have died around the world in connection with the coronavirus. He called for at-risk groups to be fully vaccinated, an increase in testing and early use of antivirals, an expansion of lab networks, and a fight against “misinformation” about the pandemic.
"We remain hopeful that in the coming year, the world will transition to a new phase in which we reduce hospitalizations and deaths to the lowest possible level,” he said.
Tedros' comments came moments after WHO released findings of its emergency committee on the pandemic which reported that some 13.1 billion doses of COVID-19 vaccines have been administered — with nearly 90% of health workers and more than four in five people over 60 years of age having completed the first series of jabs.
“The committee acknowledged that the COVID-19 pandemic may be approaching an inflexion point," WHO said in a statement. Higher levels of immunity worldwide through vaccination or infection “may limit the impact” of the virus that causes COVID-19 on “morbidity and mortality,” the committee said.
“(B)ut there is little doubt that this virus will remain a permanently established pathogen in humans and animals for the foreseeable future,” it said. While Omicron versions are easily spread, “there has been a decoupling between infection and severe disease” compared to that of earlier variants.
Committee members cited “pandemic fatigue" and the increasing public perception that COVID-19 isn't as much of a risk as it once was, leading to people to increasingly ignore or disregard health measures like mask-wearing and social distancing.
What's being called an unprecedented breakthrough in cancer treatment recently completed a small trial at New York City's Memorial Sloan Kettering in 14 rectal cancer patients. The experimental trial with the drug dostarlimab resulted in 100 percent remission in all candidates, precluding the need for chemotherapy or surgery. Cheddar News anchor Hena Doba dives into this hopeful story.
Join Cheddar News as we break down the top headlines this morning including updates on the Jan. 6 hears, the PGA suspension of 17 of the world's best golfers, and NASA's plans to study UFOs.
Rick Pauls, President & CEO OF DiaMedica Therapeutics, joins Cheddar Innovates to discuss a new ischemic stroke treatment option that expands the window for effective therapy for stroke patients.
John Bencich, CEO of Achieve Life Sciences, joins Cheddar Innovates to discuss a new plant-based compound that's being used to fight nicotine addiction.
On this episode of Cheddar Innovates: CEO of Achieve Life Sciences discusses a new plant-based compound that's being used to fight nicotine addiction; President & CEO OF DiaMedica Therapeutics explains a new ischemic stroke treatment option that expands the window for effective therapy for stroke patients; Cheddar gets a look at Curiosity Stream's 'Asteroid Rush.'
Catching you up on the stories you need to know this morning, mass shooting victims testify on Capitol Hill, the White House outlines its plan to vaccinate kids younger than five years old, and we break down how to protect yourself from monkeypox.
The pharmaceutical giant Moderna says its updated 'bivalent' booster shot provides a stronger immune response against the Omicron variant of COVID-19 specifically. This week, Moderna plans to submit preliminary data to U.S. health officials in the hopes that its new booster will be available later this summer. Dr. Sampson Davis, emergency medicine physician, joins Cheddar News to discuss.
NASA has announced that the first official full-color images will be beamed back to Earth from the James Webb Telescope on July 12. Gregory L. Robinson, the director of the James Webb Space Telescope Program in the NASA Science Mission Directorate, joined Cheddar News to discuss the anticipated image drop. “We expect to see the universe different," he said. "Webb will allow us to see much, much clearer and deeper into the universe."
On this episode of Cheddar Reveals, Professor Laurence Hurst, Director of The Milner Centre for Evolution, discusses the mystery of human evolution that's still baffling scientists: why are humans still evolving, and why has the process sped up? Neville Sanjana, faculty member at NY Genome and New York University, breaks down the latest innovations in CRISPR genetic engineering and its applications from 'designer babies' to curing genetic conditions and diseases; Cheddar gets a look at Curiosity Stream's 'The Butterfly Effect.'
Neville Sanjana, faculty member at NY Genome and New York University, joins Cheddar Reveals to break down the latest innovations in CRISPR genetic engineering and its applications from 'designer babies' to curing genetic conditions and diseases.
